New blood test could help doctors better manage Wilson's disease

NCT ID NCT05783687

Completed Knowledge-focused Sponsor: Orphalan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a new blood test that measures copper levels in people with Wilson's disease, a rare condition where copper builds up in the body. Researchers collected extra blood samples from 50 adults during routine visits over about a year. The goal was to see if this test can help doctors adjust treatment more accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WILSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Wilson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WILSON DISEASE

Contacts and locations

Locations

Advent Health Orlando

Orlando, Florida, 32803, United States
John Hopkins Hospital

Baltimore, Maryland, 21287, United States
New York Presbyterian Hospital-Columbia University Medical Centre

New York, New York, 10032, United States
Northwestern University Chicago (Hepatologist)

Chicago, Illinois, 60611, United States
UC Davis Midtown Ambulatory Care Centre

Sacramento, California, 95817, United States
University of Miami

Miami, Florida, 33136, United States
University of Michigan

Ann Arbor, Michigan, 48109, United States
Vanderbilt University Medical Centre

Nashville, Tennessee, 37212, United States
Yale University School of Medicine

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.